jcp From-the-Field

From The Field

From the Field

Evolving the Delivery of CAR T-Cell Therapies to the Outpatient Setting

10/15/2018

Abstract: The availability of adoptive cell therapies allows clinicians to genetically reprogram patients’ own immune cells to find and attack cancer cells throughout the body. Chimeric antigen receptor (CAR)...

...

10/15/2018

Journal of Clinical Pathways

From the Field

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program

06/08/2018

Jonathan Gerber , MD;

Zainab Shahi ;

Saad Z. Usmani , MD, FACP;

Michael R. Grunwald , MD;

Jigar Trivedi , MS, PharmD, BCOP;

Tammy Cogdill , MSN, ANP-BC, OCN;

Nilanjan Ghosh , MD, PhD;

Belinda R. Avalos , MD;

Dragos Plesca , PharmD, PhD, BCOP;

Manisha Bhutani , MD, PhD;

To read the full article, click here.

To...

06/08/2018

Journal of Clinical Pathways

From the Field

A Novel Clinical Pathways Approach to Delivering Regional-Based Clinical Trials and Patient Care in a Hybrid Academic-Community-Based System

05/15/2018

Kathryn E, Patronik , MHA;

Edward S. Kim , MD, FACP, MBA;

Abstract: The health care landscape is becoming constantly more complex with new drug treatments and molecular testing. In order to achieve consistent, up-to-date patient care, clinical pathways are becoming...

...

05/15/2018

Journal of Clinical Pathways

From the Field

A Community Practice Perspective on Implementation of the Oncology Care Model

05/15/2018

Anne Marie Fraley Rainey , MSN, RN, CHC;

Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model (OCM), an innovative pilot project sponsored by the Centers for Medicare and Medicaid Innovation....

...

05/15/2018

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: Exploring the Process of Developing a Pathway for Metastatic Breast Cancer

02/15/2018

Bruce A. Feinberg , DO;

Chadi Nabhan , MD, MBA, FACP;

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...

Abstract: Clinical...

02/15/2018

Journal of Clinical Pathways

From the Field

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program

04/11/2017

Belinda R. Avalos , MD;

Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...

...

04/11/2017

Journal of Clinical Pathways

From the Field

A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways

10/12/2016

Joleen Hubbard , MD;

Angelina Tan ;

Katrina Croghan , MS;

Juliana Perez Botero , MD;

Briant Fruth ;

Deirdre Pachman , MD;

Veronica Lafky ;

Jeff Sloan , PhD;

Carrie Thompson , MD;

Rahma Warsame , MD;

Angela Dispenzieri , MD;

Abstract: Modern clinical practice places restrictions on the amount of information communicated in a typical office visit, impeding patient concerns from being adequately addressed. A point-of-care case management...

...

10/12/2016

Journal of Clinical Pathways

From the Field

A Method of Deriving Estimates of Health State Utilities for Patients With Metastatic Breast Cancer

06/20/2016

Gabriel Tremblay , DBA, MSc;

Stacie Hudgens , MA, MSc;

Andrew Briggs , DPhil, MSc;

Andrew J. Lloyd , DPhil;

Anna Forsythe , PharmD, MBA, MSc;

Abstract Patient-level health-related quality of life (HRQOL) for different stages of metastatic breast cancer (MBC) and chemotherapy regimen toxicities are useful for health economic assessments. However, it is...

...

06/20/2016

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: A Method for Exploring the Oncology Clinical Pathway Development Process

05/06/2016

Bing-E Xu , PhD;

Bruce A. Feinberg , DO;

Monica Lingam , MS;

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...

...

05/06/2016

Journal of Clinical Pathways

From the Field

Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center

04/11/2016

Aymen Elfiky , MD, MPH, MSc;

Marina Kaymakcalan , PharmD;

Abstract: The rising costs associated with cancer care delivery have prompted the health care system to prioritize the principle of value-based care to accentuate the concepts of quality and outcomes. Driven in...

...

04/11/2016

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

From The Field

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products